- Home
- POLA vs MYNZ Comparison
POLA vs MYNZ Comparison
Compare POLA & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- MYNZ
- Stock Information
- Founded
- POLA 1979
- MYNZ 2021
- Country
- POLA United States
- MYNZ Germany
- Employees
- POLA N/A
- MYNZ N/A
- Industry
- POLA Industrial Machinery/Components
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- POLA Miscellaneous
- MYNZ Health Care
- Exchange
- POLA Nasdaq
- MYNZ Nasdaq
- Market Cap
- POLA 4.3M
- MYNZ 5.5M
- IPO Year
- POLA 2016
- MYNZ 2021
- Fundamental
- Price
- POLA $1.91
- MYNZ $1.92
- Analyst Decision
- POLA
- MYNZ Buy
- Analyst Count
- POLA 0
- MYNZ 2
- Target Price
- POLA N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- POLA 278.0K
- MYNZ 154.3K
- Earning Date
- POLA 08-13-2025
- MYNZ 07-22-2025
- Dividend Yield
- POLA N/A
- MYNZ N/A
- EPS Growth
- POLA N/A
- MYNZ N/A
- EPS
- POLA N/A
- MYNZ N/A
- Revenue
- POLA $13,918,000.00
- MYNZ $893,991.00
- Revenue This Year
- POLA N/A
- MYNZ $26.06
- Revenue Next Year
- POLA N/A
- MYNZ $4.97
- P/E Ratio
- POLA N/A
- MYNZ N/A
- Revenue Growth
- POLA 8.08
- MYNZ N/A
- 52 Week Low
- POLA $1.53
- MYNZ $1.34
- 52 Week High
- POLA $4.90
- MYNZ $20.08
- Technical
- Relative Strength Index (RSI)
- POLA 62.97
- MYNZ 57.87
- Support Level
- POLA $1.82
- MYNZ $1.35
- Resistance Level
- POLA $1.97
- MYNZ $2.15
- Average True Range (ATR)
- POLA 0.16
- MYNZ 0.13
- MACD
- POLA 0.03
- MYNZ 0.10
- Stochastic Oscillator
- POLA 33.70
- MYNZ 71.67
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.